Peptide Guide + Calculator
BPC-157 Reconstitution Calculator & Guide
Body Protection Compound 157
BPC-157 is an experimental synthetic peptide widely discussed for tendon, ligament, muscle, joint, and gastrointestinal recovery. Most published evidence remains preclinical, while human research is very limited. This page explains the current evidence, safety and regulatory status, common comparisons with TB-500, and educational BPC-157 reconstitution math.
Evidence Snapshot
BPC-157 research at a glance
Standardized regulatory and evidence context so research compounds, investigational drugs, and approved medications are not treated as if they have the same level of human evidence.
Regulatory status
Not FDA-approvedDevelopment / evidence stage
Exploratory human evidence
No established development program
Human evidence level
Very limited human evidencePrimary mechanism
Synthetic 15-amino-acid peptide with proposed repair-related signaling effects derived largely from preclinical models.
WADA context
Explicitly prohibited — S0Human intervention evidence
Only very small exploratory or uncontrolled human reports are available. There is no completed Phase 2 program or validated pharmaceutical treatment regimen.
Human biology evidence
Most evidence comes from animal and laboratory models involving gastrointestinal, tendon, ligament, muscle, nerve, and wound-healing pathways.
Key takeaway
BPC-157 has a large online reputation but a very small direct human evidence base relative to the strength of the claims made for it.
Evidence labels describe the research base and regulatory context; they are not treatment, dosing, or use recommendations. Review dates describe the last BACToBasics source check for this evidence summary. Anti-doping rules can change and should be verified with the applicable authority.
BPC-157 Reconstitution Calculator
Enter the vial amount, liquid volume, and amount you want to calculate. BACToBasics will automatically calculate concentration, liquid volume, and U-100 syringe-unit equivalents.
Loading calculator...
Calculator values are educational math inputs only. They are not recommended preparation amounts, doses, or use protocols.
BPC-157 Reconstitution Math
Reconstitution math starts with the amount contained in the vial and the liquid volume used in the calculation. Dividing the vial amount by the liquid volume gives the resulting concentration.
Example vial amount
5 mg
| Liquid Volume | Calculation | Concentration |
|---|---|---|
| 1 mL | 5 mg ÷ 1 mL | 5 mg/mL |
| 2 mL | 5 mg ÷ 2 mL | 2.5 mg/mL |
| 3 mL | 5 mg ÷ 3 mL | 1.6667 mg/mL |
This table demonstrates concentration math only. The liquid volumes shown are examples for comparison and are not preparation recommendations.
More Reconstitution Tools
Need to compare different liquid volumes or convert between mg, mcg, mL, and U-100 units? Use the dedicated BACToBasics calculator tools.
What is BPC-157?
BPC-157 is a synthetic 15-amino-acid peptide derived from a sequence associated with gastric proteins. It has attracted attention because animal and laboratory studies have reported effects involving tissue repair, blood-vessel signaling, inflammation, gastrointestinal injury, and musculoskeletal healing. BPC-157 is not an FDA-approved medication.
What does the research on BPC-157 actually show?
Most BPC-157 research has been performed in animals or laboratory models rather than large controlled human trials. Preclinical studies have explored tendon, ligament, muscle, bone, nerve, gastrointestinal, and wound-healing models, but promising animal findings do not establish that the same benefits occur in humans.
How much human research exists on BPC-157?
Human evidence remains extremely limited. Recent reviews have noted that available clinical information comes from only a small number of participants across uncontrolled or preliminary studies, with no completed Phase II clinical trial and no validated pharmaceutical dosing regimen. A small 2025 intravenous pilot study involved only two adults and reported no adverse effects during the short observation period, which is far too small to establish overall safety or effectiveness.
BPC-157 for tendon and ligament recovery
Tendon and ligament recovery are among the most common reasons BPC-157 is discussed online. Animal research has reported effects involving tendon-to-bone healing, fibroblast activity, blood-vessel formation, and tissue organization. However, controlled human evidence demonstrating improved tendon or ligament healing remains lacking.
BPC-157 for muscle and injury recovery
BPC-157 is frequently discussed in bodybuilding and sports communities for muscle strains, soft-tissue injuries, and general recovery. These claims are largely extrapolated from preclinical research and user reports rather than established human clinical trials.
BPC-157 and gut health
BPC-157 has also been studied extensively in experimental gastrointestinal models, which is one reason it is often discussed for stomach and intestinal conditions. In 2026, FDA reviewers evaluated BPC-157-related bulk drug substances in the context of ulcerative colitis, but concluded that available clinical evidence and safety information were insufficient to characterize its safety for proposed human uses.
BPC-157 vs TB-500
BPC-157 and TB-500 are commonly compared because both are discussed in injury-recovery communities. BPC-157 is often associated with localized tendon, ligament, muscle, and gastrointestinal research, while TB-500 is commonly discussed around broader wound-healing and tissue-repair mechanisms related to thymosin beta-4. Neither should be assumed to have proven human recovery benefits based on online comparisons.
What is known about BPC-157 safety?
The long-term safety profile of BPC-157 in humans is not established. FDA has cited insufficient human safety information as well as potential concerns involving immunogenicity, peptide aggregation, impurities, and characterization of the active pharmaceutical ingredient. Small preliminary reports cannot rule out uncommon, delayed, dose-related, or long-term adverse effects.
Is BPC-157 FDA-approved?
No. BPC-157 is not an FDA-approved drug. FDA has specifically reviewed BPC-157-related bulk drug substances in the compounding context and has stated that available information is insufficient to determine whether proposed compounded BPC-157 products would cause harm when administered to humans.
Is BPC-157 banned in competitive sports?
Yes. BPC-157 is included under the World Anti-Doping Agency's S0 category for non-approved substances and is prohibited at all times for athletes subject to WADA rules, including both in-competition and out-of-competition periods.
Research BPC-157 vs an approved medication
Products marketed online as research BPC-157 should not be treated as equivalent to an FDA-approved pharmaceutical product. There is no FDA-approved BPC-157 product with standardized manufacturing, purity, concentration, sterility, labeling, or an established clinical dosing regimen.
BPC-157 reconstitution math
Reconstitution calculations depend on the labeled amount in a vial and the liquid volume used. As a math example, a 5mg vial combined with 2mL of liquid produces a concentration of 2.5mg per mL, or 2,500mcg per mL. BACToBasics uses examples like this only to demonstrate concentration, liquid-volume, and U-100 syringe-unit calculations rather than to recommend a preparation or dosing protocol.
Explore more about BPC-157
16 linksComparisons, research records, development tracking, blends, and related guides are available here when you want to go deeper.
Explore more about BPC-157
16 linksComparisons, research records, development tracking, blends, and related guides are available here when you want to go deeper.
Compare BPC-157
Direct comparison pages are selected from the indexable BACToBasics comparison catalog and update automatically as that catalog grows.
Research, updates & development
Jump from the guide into the public update timeline, compound-specific research records, and clinical-development tracker without searching again.
BPC-157 research & development updates
Open the public timeline of sourced research records and material development changes tracked by BACToBasics.
Open →
ResearchBPC-157 research sources
Open 3 curated research records for BPC-157.
Open →
DevelopmentBPC-157 clinical development
Exploratory human evidence · No established development program. Limited exploratory human evidence; no validated late-stage therapeutic program identified.
Open →
Blend guides containing BPC-157
These pages are derived from blend component metadata, so a new blend automatically becomes discoverable from each linked component guide.
Related peptide guides
Related guides are ranked from shared comparison pages, shared blend pages, and peptide category rather than a hand-maintained link list.
TB-500 guide & calculator
Recovery & Healing · Thymosin Beta-4 Fragment
Open →
Peptide guideGHK-Cu guide & calculator
Skin & Hair · Copper-Binding Tripeptide
Open →
Peptide guideKPV guide & calculator
Recovery & Healing · α-MSH-Derived Tripeptide
Open →
Peptide guideLL-37 guide & calculator
Recovery & Healing · Cathelicidin Antimicrobial Peptide / CAMP
Open →
Relevant glossary concepts
Definitions are matched against the guide's structured title, subtitle, description, and educational sections.
FDA-Approved
A status indicating that the FDA has approved a specific drug product for one or more labeled uses after reviewing the required evidence and manufacturing information.
Open →
GlossaryMilliliter (mL)
A metric unit of liquid volume equal to one-thousandth of a liter.
Open →
GlossaryConcentration
The amount of a substance contained in a given volume of liquid, such as mg/mL or mcg/mL.
Open →
BPC-157 FAQ
Tap a question to expand only the answer you want to read.
Is BPC-157 FDA-approved?
No. BPC-157 is not an FDA-approved medication. FDA has also raised concerns about the limited human safety information available for compounded BPC-157 products.
Does BPC-157 actually heal tendons?
Animal and laboratory research has produced findings involving tendon healing and tissue repair, but controlled human clinical evidence proving that BPC-157 heals tendon injuries is currently lacking.
Does BPC-157 help ligaments?
Ligament and connective-tissue recovery are commonly discussed uses of BPC-157, largely because of preclinical research. Human evidence establishing a clinical benefit for ligament injuries remains insufficient.
Does BPC-157 help muscle injuries?
BPC-157 has been studied in preclinical muscle-injury models and is widely discussed for sports recovery, but there is not enough controlled human evidence to establish that it improves muscle-injury recovery.
Is there human research on BPC-157?
Yes, but very little. Human evidence consists of small preliminary or uncontrolled studies rather than large randomized clinical trials. Current reviews emphasize that the human evidence base remains extremely limited.
Is BPC-157 safe?
Its overall safety in humans is not established. FDA has stated that human safety information is insufficient and has identified potential concerns involving immune reactions, peptide impurities, aggregation, and product characterization.
What are the side effects of BPC-157?
There is not enough high-quality human research to define a reliable side-effect profile. Symptoms such as headache, nausea, fatigue, and injection-site reactions are discussed online, but anecdotal reports cannot establish frequency or causality.
Why do people combine BPC-157 and TB-500?
The two are frequently discussed together because both have preclinical research related to tissue repair and healing. Their combination is popular in online recovery communities, but that does not establish that the combination is safe or effective in humans.
Is BPC-157 banned by WADA?
Yes. BPC-157 is prohibited under WADA's S0 category for non-approved substances and is prohibited at all times for athletes covered by WADA rules.
Is BPC-157 measured in mg or mcg?
Products labeled as BPC-157 are often described in milligrams at the vial level, while smaller mathematical quantities may be expressed in micrograms. One milligram equals 1,000 micrograms.
How do you calculate BPC-157 reconstitution concentration?
Divide the labeled vial amount by the liquid volume. For example, 5mg divided by 2mL equals 2.5mg/mL, which is also 2,500mcg/mL. This is concentration math rather than a recommendation for how a product should be prepared.
Can the BACToBasics calculator handle BPC-157 math?
Yes. Enter a labeled vial amount and liquid volume to calculate concentration, equivalent liquid volume, U-100 syringe units, and approximate amounts per vial. The calculator provides educational math rather than dosing advice.
Sources & References
5 sourcesOpen the references when you want to inspect the research and regulatory sources behind this guide.
Sources & References
5 sourcesOpen the references when you want to inspect the research and regulatory sources behind this guide.
FDA identifies limited human safety information and potential concerns involving immunogenicity, peptide impurities, aggregation, and active-ingredient characterization.
FDA's 2026 review concluded that clinical safety information was insufficient to characterize the safety profile of BPC-157 and BPC-157 acetate for the evaluated uses.
Recent review of BPC-157 development describing extensive preclinical research but very limited human evidence, no validated dosing regimen, and no completed Phase II clinical trial.
Small pilot study involving two adults receiving intravenous BPC-157. No adverse effects were reported during the study, but the sample size was far too small to establish general safety.
BPC-157 is listed under S0, Non-Approved Substances, and is prohibited at all times for athletes subject to WADA rules.
BACToBasics provides educational information and math tools only. This content is not medical advice, dosing advice, injection instruction, or a recommendation to use any peptide or medication.